混合型肝细胞-胆管细胞癌:2019年世界卫生组织组织学分类系统的变化及其对影像诊断的潜在影响
混合型肝细胞-胆管细胞癌(cHCC-CCA)具有肝细胞和胆管细胞两种表型。2019年WHO新版组织学分类不再承认具有干细胞特征的cHCC-CCA亚型,并将部分此类亚型重新归类为肝细胞癌(HCC)或肝内胆管癌(ICC),同时推荐了中间细胞癌和胆管细胞癌(原胆管细胞癌亚型)的独立诊断术语。本文综述2019年WHO分类系统,阐述各亚型的影像特征,并讨论其对基于影像的HCC诊断的影响。
要点
- 2019年WHO分类不再承认具有干细胞特征的cHCC-CCA亚型,部分被重新归类为HCC或ICC。
- cHCC-CCA在影像上常表现为HCC模仿者、ICC模仿者或不确定性病变。
- 放射科医生需了解新版分类变化,因其可能影响基于影像的HCC诊断。
核心结论
- 2019年WHO新版组织学分类不再承认具有干细胞特征的cHCC-CCA亚型,部分此类亚型被重新归类为HCC或ICC。
- 新版分类推荐了中间细胞癌和胆管细胞癌(原胆管细胞癌亚型)的独立诊断术语。
- cHCC-CCA在影像上常表现为HCC模仿者、ICC模仿者或不确定性病变,分类变化可能影响基于影像的HCC诊断。
研究设计与样本
- 本文为综述,介绍2019年WHO cHCC-CCA组织学分类系统,阐述其亚型的影像特征,讨论对基于影像的HCC诊断的影响。
关键影像表现/征象
- cHCC-CCA在影像学检查中常表现为HCC模仿者、ICC模仿者或不确定性病变。
临床应用与阅片要点
- 放射科医生应了解2019年WHO分类变化,因其可能影响基于影像的HCC诊断。
- 阅片时需注意cHCC-CCA可表现为HCC模仿者、ICC模仿者或不确定性病变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a primary liver cancer (PLC) with both hepatocytic and cholangiocytic phenotypes. Recently, the World Health Organization (WHO) updated its histological classification system for cHCC-CCA. Compared to the previous WHO histological classification system, the new version no longer recognizes subtypes of cHCC-CCA with stem cell features. Furthermore, some of these cHCC-CCA subtypes with stem cell features have been recategorized as either hepatocellular carcinomas (HCCs) or intrahepatic cholangiocarcinomas (ICCs). Additionally, distinctive diagnostic terms for intermediate cell carcinomas and cholangiolocarcinomas (previous cholangiolocellular carcinoma subtype) are now recommended. It is important for radiologists to understand these changes because of its potential impact on the imaging-based diagnosis of HCC, particularly because cHCC-CCAs frequently manifest as HCC mimickers, ICC mimickers, or as indeterminate on imaging studies. Therefore, in this review, we introduce the 2019 WHO classification system for cHCC-CCA, illustrate important imaging features characteristic of its subtypes, discuss the impact on imaging-based diagnosis of HCC, and address other important considerations.
引用
- Kim TH, Kim H, Joo I, et al. Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis. Korean J Radiol. 2020. PMID: 32729276. doi:10.3348/kjr.2020.0091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。